Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia.

Hou Q, Liao F, Zhang S, Zhang D, Zhang Y, Zhou X, Xia X, Ye Y, Yang H, Li Z, Wang L, Wang X, Ma Z, Zhu Y, Ouyang L, Wang Y, Zhang H, Yang L, Xu H, Shu Y.

Oncotarget. 2017 May 30;8(22):36040-36053. doi: 10.18632/oncotarget.16424.

2.

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.

Shuvalov O, Petukhov A, Daks A, Fedorova O, Vasileva E, Barlev NA.

Oncotarget. 2017 Apr 4;8(14):23955-23977. doi: 10.18632/oncotarget.15053. Review.

3.

Detecting subnetwork-level dynamic correlations.

Yan Y, Qiu S, Jin Z, Gong S, Bai Y, Lu J, Yu T.

Bioinformatics. 2017 Jan 15;33(2):256-265. doi: 10.1093/bioinformatics/btw616. Epub 2016 Sep 25.

PMID:
27667792
4.

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.

Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, Vora A, Baruchel A, Silverman LB, Schmiegelow K, Escherich G, Horibe K, Benoit YC, Izraeli S, Yeoh AE, Liang DC, Downing JR, Evans WE, Relling MV, Mullighan CG.

J Clin Oncol. 2015 Sep 20;33(27):2938-48. doi: 10.1200/JCO.2014.59.1636. Epub 2015 Aug 24. Review.

5.

MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis.

Peng H, Ma J, Bai Y, Lu J, Yu T.

PLoS One. 2015 Apr 27;10(4):e0124620. doi: 10.1371/journal.pone.0124620. eCollection 2015.

6.

Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia.

Garza-Veloz I, Martinez-Fierro ML, Jaime-Perez JC, Carrillo-Sanchez K, Ramos-Del Hoyo MG, Lugo-Trampe A, Rojas-Martinez A, Gutierrez-Aguirre CH, Gonzalez-Llano O, Salazar-Riojas R, Hidalgo-Miranda A, Gomez-Almaguer D, Ortiz-Lopez R.

Dis Markers. 2015;2015:828145. doi: 10.1155/2015/828145. Epub 2015 Feb 24.

7.

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Castellino SM, Ullrich NJ, Whelen MJ, Lange BJ.

J Natl Cancer Inst. 2014 Jul 30;106(8). pii: dju186. doi: 10.1093/jnci/dju186. Print 2014 Aug. Review.

8.

Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.

Schmiegelow K, Nielsen SN, Frandsen TL, Nersting J.

J Pediatr Hematol Oncol. 2014 Oct;36(7):503-17. doi: 10.1097/MPH.0000000000000206. Review.

9.

Integrative gene set analysis: application to platinum pharmacogenomics.

Fridley BL, Abo R, Tan XL, Jenkins GD, Batzler A, Moyer AM, Biernacka JM, Wang L.

OMICS. 2014 Jan;18(1):34-41. doi: 10.1089/omi.2013.0099. Epub 2013 Nov 7.

10.

Independent validation of a model using cell line chemosensitivity to predict response to therapy.

Wang W, Baggerly KA, Knudsen S, Askaa J, Mazin W, Coombes KR.

J Natl Cancer Inst. 2013 Sep 4;105(17):1284-91. doi: 10.1093/jnci/djt202. Epub 2013 Aug 20.

11.

Mathematical modeling of folate metabolism.

Panetta JC, Paugh SW, Evans WE.

Wiley Interdiscip Rev Syst Biol Med. 2013 Sep-Oct;5(5):603-13. doi: 10.1002/wsbm.1227. Epub 2013 May 22.

12.

Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors.

Vazquez A, Tedeschi PM, Bertino JR.

Cancer Res. 2013 Jan 15;73(2):478-82. doi: 10.1158/0008-5472.CAN-12-3709. Epub 2012 Nov 7.

13.
14.

Capturing changes in gene expression dynamics by gene set differential coordination analysis.

Yu T, Bai Y.

Genomics. 2011 Dec;98(6):469-77. doi: 10.1016/j.ygeno.2011.09.001. Epub 2011 Sep 24.

15.

Integrated analysis of pharmacologic, clinical and SNP microarray data using Projection Onto the Most Interesting Statistical Evidence with Adaptive Permutation Testing.

Pounds S, Cao X, Cheng C, Yang JJ, Campana D, Pui CH, Evans WE, Relling MV.

Int J Data Min Bioinform. 2011;5(2):143-57. doi: 10.1504/IJDMB.2011.039174.

16.

Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.

Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Boyett JM, Raimondi SC, Panetta JC, Bowman WP, Sandlund JT, Pui CH, Relling MV, Evans WE.

J Clin Oncol. 2011 May 1;29(13):1771-8. doi: 10.1200/JCO.2010.32.5340. Epub 2011 Mar 28.

17.

Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.

Dettman EJ, Simko SJ, Ayanga B, Carofino BL, Margolin JF, Morse HC 3rd, Justice MJ.

Oncogene. 2011 Jun 23;30(25):2859-73. doi: 10.1038/onc.2011.12. Epub 2011 Feb 21.

18.

PharmGKB summary: methotrexate pathway.

Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB.

Pharmacogenet Genomics. 2011 Oct;21(10):679-86. doi: 10.1097/FPC.0b013e328343dd93. No abstract available.

19.

Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells.

Panetta JC, Sparreboom A, Pui CH, Relling MV, Evans WE.

PLoS Comput Biol. 2010 Dec 2;6(12):e1001019. doi: 10.1371/journal.pcbi.1001019.

20.

Pharmacogenomics in pediatric leukemia.

Paugh SW, Stocco G, Evans WE.

Curr Opin Pediatr. 2010 Dec;22(6):703-10. doi: 10.1097/MOP.0b013e32833fde85. Review.

Supplemental Content

Support Center